Contrary to expectations, adolescents with first-episode psychosis who had a family history of psychosis actually showed milder positive symptoms at onset, and family history rates did not differ between psychotic and non-psychotic mental illness.
Readers interested in how genetics and family history relate to psychosis risk in young people.
Family history of psychosis was linked to lower positive symptom scores at first episode (p = 0.009)
What the researchers found
Researchers compared 45 adolescents with first-episode early-onset psychosis (EOP) to 45 age- and gender-matched adolescents with non-psychotic mental illness. Family history of psychosis did not significantly differ between the two groups.
However, among the psychotic adolescents, those with a positive family history of psychosis had significantly lower positive symptom scores on the PANSS (p = 0.009), meaning fewer hallucinations, delusions, and other positive symptoms at the time of first presentation. Family history was not associated with other clinical features.
Notably, adolescents with non-psychotic mental illness were significantly more likely to have a family history of non-psychotic mental illness (47%) compared to the psychotic group (13%, p = 0.001).
Why it matters
The assumption that family history of psychosis predicts worse outcomes may not hold true at disease onset in adolescents. This finding could influence how clinicians interpret family history when evaluating young people with first psychotic episodes. The inclusion of cannabis screening adds context to understanding substance use patterns in this population.
The numbers in context
45 psychotic adolescents vs. 45 matched controls. Family history of non-psychotic mental illness: 13% in EOP group vs. 47% in controls (p = 0.001). Positive family history of psychosis was associated with lower PANSS positive scores (p = 0.009).
How the study worked
This was a case-control study at psychiatric services in South Africa. Forty-five adolescents with first-episode psychosis were matched with 45 controls who had non-psychotic mental illness. Assessments included the PANSS for symptom severity, the SOS inventory for symptom onset, and the WHO ASSIST screening tool for cannabis use.
What this study cannot tell us
Small sample size (45 per group) limits statistical power. The study was conducted at a single site in South Africa, which may limit generalizability. Cannabis use data was collected but the abstract does not detail specific associations with outcomes. Cross-sectional design captures only the initial presentation, not long-term trajectory.
How to read the evidence
Preliminary evidence from a small, single-site case-control study.
When this study was published
Published in 2017. South African study on adolescent psychosis.
The bigger picture
Understanding the relationship between family history, genetics, and early-onset psychosis is critical for early intervention. This study challenges the simple narrative that family history equals worse outcomes and suggests the genetics of psychosis susceptibility may operate differently in adolescents than in adults.
Questions still open
- Why would family history of psychosis be associated with milder initial symptoms? Does this pattern hold over time, or do these patients eventually develop more severe symptoms? What role did cannabis use play in the onset of psychosis in these adolescents?
Common questions
Does this study mean family history of psychosis is protective?
What role did cannabis play in this study?
Read the original research
The clinical impact of a positive family history of psychosis or mental illness in psychotic and non-psychotic mentally ill adolescents.
Journal of child and adolescent mental health, 29(3), 219-229
Citation
Paruk, Saeeda; Jhazbhay, Khatija; Singh, Keshika; Sartorius, Benn; Burns, Jonathan K. (2017). The clinical impact of a positive family history of psychosis or mental illness in psychotic and non-psychotic mentally ill adolescents.. Journal of child and adolescent mental health, 29(3), 219-229. https://doi.org/10.2989/17280583.2017.1389741
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)